{{NoteTA|zh-tw:退热药;zh-hans:退热药}}
{{medical}}
{{drugbox
 | IUPAC_name = 钠 [(2,3-二氢-1,5-乙烷-3-酮-2-苯基-1H-吡唑-4-yl)甲氨基] 甲磺酸盐
 | image = Metamizol.svg
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 68-89-3
| CAS_supplemental = (sodium salt)
| ATC_prefix = N02
| ATC_suffix = BB02
| PubChem = 80254
| PubChem2 = 3111
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04817
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3000
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VSU62Z74ON
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 59033
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 487894
 | C=13 | H=16 | N=3 | Na=1 | O=4 | S=1
 | molecular_weight = 333.337 g/mol
| DrugBank = DB04817
| ChemSpiderID = 3000
| smiles = Cc1c(c(=O)n(n1C)c2ccccc2)N(C)CS(=O)(=O)O
| StdInChI = 1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)
| StdInChIKey = LVWZTYCIRDMTEY-UHFFFAOYSA-N
<!--Pharmacokinetic data-->
| bioavailability = 100% (active metabolites)><ref name = deranaes2008>{{cite journal|last1=Jage|first1=J|last2=Laufenberg-Feldmann |first2=R |last3=Heid |first3=F|title=Medikamente zur postoperativen Schmerztherapie: Bewährtes und Neues|trans_title=Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids|journal=Der Anaesthesist|date=20 March 2008|volume=57|issue=4|pages=382–390|doi=10.1007/s00101-008-1326-x|pmid=18351305|language=de}}</ref>
| protein_bound = 48%-58% (active metabolites)<ref name = deranaes2008/>
| metabolism = 肝脏<ref name = deranaes2008/>
| elimination_half-life = 14分钟 (母体分子);<ref name = SPC/> 代谢物: 2–4 hours<ref name = deranaes2008/>
| excretion = 尿液(96%, IV; 85%, 口服), 粪便 (4%, IV)<ref name = SPC>{{cite web|title=Fachinformation (Zusammenfassung der Merkmale des Arzneimittels) Novaminsulfon injekt 1000 mg Lichtenstein Novaminsulfon injekt 2500 mg Lichtenstein|url=http://www.zentiva.de/Home/Medikamente-und-Produkte/Produkte.htm?ID=28&cmd=getFile&getFile_cid=0900972f80210633|language=de|date=February 2013|accessdate=19 April 2014|work=Winthrop Arzneimittel GmbH|publisher=Zinteva Pharm GmbH}}</ref>
 }}

'''安乃近'''（英文名 Metamizole Sodium；Metamizole、dipyrone、Sulpyrine），，一种解热镇痛药，1920年被德国 Hoechst AG公司合成，1922年开始批量生产。

==化学合成==
由氨基比林、甲醛和[[亚硫酸钠|亚硫酸钠]]缩合得到。
[[Image:Metamizole_sodium_synthesis.svg|安乃近的合成路线]]

==适应症==
用于发热，各种疼痛，如关节疼，肌肉疼等。

==粒细胞缺乏症==
长期服用安乃近可能会导致[[粒细胞|粒细胞]]缺乏症，很危险，因此1977年美国将安乃近禁用，日本，澳大利亚，伊朗，和几个欧盟成员国等纷纷效仿，但还有不少国家仍在使用，没有禁止，甚至成为最流行的解热镇痛药。{{Fact}}

==参考文献==
{{reflist}}

==參見==
*[[洛索洛芬|洛索洛芬]](Loxoprofen (INN))
*[[傳明酸|傳明酸]]

{{Anti-inflammatory products}}

[[Category:非甾体抗炎药|]]